The Development and Maintenance of Human Visceral Pain Hypersensitivity Is Dependent on the N-Methyl-D-Aspartate Receptor

Gastroenterology

Volumn 126, Issue 3, 2004, Pages 683-692

  Willert, Robert Paul ^a   Woolf, Clifford J ^b   Hobson, Anthony Robert ^a   Delaney, Claire ^a   Thompson, David G ^a   Aziz, Qasim ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AREA UNDER THE CURVE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROSTIMULATION; ESOPHAGUS PH; HUMAN; NERVE EXCITABILITY; NOCICEPTION; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR INTRINSIC ACTIVITY; SENSITIZATION; SPINAL CORD NERVE CELL; VISCERAL PAIN;

EID: 1542317629     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.11.047     Document Type: Article

References (72)

1. Gebhart GF, Ness TJ. Visceral pain: a review of experimental studies. Pain 1990;41:167-234.
2. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 1994;74:95-138.
3. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:2032-2048.
4. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973;14:125-132.
5. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:938-943.
6. Bradete M, Pare P, Douville P, Morin A. Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 1991;36:52-58.
7. Drosssman DA, Corazziari R, Talley, NJ, Thompson WG, Whitehead WE. ROME II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational consensus. Degnon Associates, 2000.
8. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990;99:1688-1704.
9. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-293.
10. Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997;112:1714-1743.
11. Woolf CJ. An overview of the mechanisms of hyperalgesia, Pulm Pharmacol 1995;8:161-167.
12. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-299.
13. Bessou P, Perl ER, Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli. J Neurophysiol 1969;32:1025-1043.
14. Campbell JN, Meyer RA, LaMotte RH. Sensitization of myelinated nociceptive afferents that innervate monkey hand. J Neurophysiol 1979;42:1669-1679.
15. Raja SN, Campbell JN, Meyer RA. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain 1984;107:1179-1188.
16. Cook AJ, Woolf CJ, Wall PD, McMahon SB. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987;325:151-153.
17. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A 1999;96:7723-7730.
18. Hayley JE, Sullivan AF, Dickenson AH. Evidence for spinal methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990;518:218-226.
19. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurons. Nature 1994;309:261-263.
20. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C fiber stimulation. Neuropharmacology 1987;26:1235-1238.
21. Dickenson AH, Sullivan AF. A cure of wind-up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990;11:307-309.
22. Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 1992;15:96-103.
23. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-1769.
24. Park KM, Max MB, Robinovitz E, Graceiy RH, Bennett GJ. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995;63:163-172.
25. Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth 1996;76:829-834.
26. Andersen OK, Felby S, Nicolaisen L, Bjerring P, Jensen TS, Arendt-Nielsen L. The effect of Ketamine on stimulation of primary and secondary hyperalgesia areas induced by capsaicin - a double-blind, placebo-controlled, human experimental study. Pain 1996;66:829-834.
27. Warncke T, Stubhaug A, Jorum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain 1997;72:99-106.
28. Graven-Nielsen T, Kendal S, Henriksson KG, Bengtsson M, Sorensen J, Johnson A, Gerdle B, Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation and referred pain in fibromyalgia patients. Pain 2000;85:483-491.
29. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 2000;356:1154-1159.
30. Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hyper-sensitivity. Am J Physiol Gastrointest Liver Physiol 2001;281: G1196-G1202.
31. Talley NJ, Phillips S, Melton U, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-674.
32. Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 1982;71:539-542.
33. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982;61:87-92.
34. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981;53:27-30.
35. Lezak MD. Neuropsychological Assessment. New York: Oxford University Press, 1995.
36. Strauss E, Spellacy F, Hunter M, Berry T. Assessing believable deficits of measures of attention and information processing capacity. Arch Clin Neuropsychol 1994;9:483-490.
37. Sarkar S, Hobson AR, Hughes A, Growcott J, Woolf CJ, Thompson DG, Aziz Q. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 2003;124:18-25.
38. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in clinical research. Br Med J 1990;300:230-235.
39. McRoberts JA, Coutinho SV, Marvizon JC, Grady EF, Tognetto M, Sengupta JN, Ennes HS, Chaban VV, Amadesi S, Creminon C, Lanthorn T, Geppetti P, Bunnett NW, Mayer EA. Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 2001;120:1737-1748.
40. Ma QP, Hargreaves RJ. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats, Neuroscience 2000;101:699-707.
41. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002;5(suppl):1039-1042.
42. Detsch O, Kochs E. Effects of ketamine on CNS-function. Anaesthesist 1997;46(suppl 1):S20-S29.
43. Adams HA. Mechanisms of action of ketamine. Anaesthesiol Reanim 1998;23:60-63.
44. Laird JM, de la Rubia PG, Cervero F. Excitability changes of somatic and viscero-somatic nociceptive reflexes in the decerebrate-spinal rabbit: role of NMDA receptors. J Physiol 1995;489:545-555.
45. Olivar T, Laird JMA. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain 1999;79:67-73.
46. Castroman PJ, Ness TJ. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder. Anesthesiology 2002;96:1401-1409.
47. Yaping JI, Traub RJ. Spinal NMDA Receptors contribute to neuronal processing of acute noxious and non-noxious colorectal stimulation in the rat. Neurophysiol 2001;86:1783-1791.
48. Coutinho SV, Meller ST, Gebhart GF. Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res 1996;736:7-15.
49. Kozlowski CM, Bountra C, Grundy D. The effect of fentanyl, DNQX and MK-801 on dorsal horn neurons responsive to colorectal distension in the anaesthetised rat. Neurogastroenterol Motil 2000;12:239-247.
50. Kuiken SD, Lei A, Tytgat GN, Holman R, Boeckxstaens GE. Effect of the low-affinity, noncompetitive N-methyl-D-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers. Aliment Pharmacol Ther 2002;16:1955-1962.
51. Hobson AR, Sarkar S, Furlong PL, Thompson DG, Aziz Q. A cortical evoked potential study of afferents mediating human esophageal sensation. Am J Physiol Gastrointest Liver Physiol 2000;279: G139-G147.
52. Lu Y, Vera-Portocarrero LP, Westlund KN. Intrathecal coadministration of D-APV and morphine is maximally effective in a rat experimental pancreatitis model. Anesthesiology 2003;98:734-740.
53. Traub RJ, Zhai Q, Ji Y, Kovalenko M. NMDA receptor antagonists attenuate noxious and nonnoxious colorectal distention-induced Fos expression in the spinal cord and the visceromotor reflex. Neuroscience 2002;113:205-211.
54. South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, Woolf CJ, Heinemann SF, Inturrisi CE. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci 2003;23:5031-5040.
55. Kochs E, Scharein E, Mollenberg O, Bromm B, Schulte am Esch J. Analgesic efficacy of low-dose ketamine. Somatosensory-evoked responses in relation to subjective pain ratings. Anesthesiology 1996;85:304-314.
56. Kolhekar R, Gebhart GF. Modulation of spinal visceral nociceptive transmission by NMDA receptor activation in the rat, J Neurophysiol 1996;75:2344-2353,
57. Ide Y, Maehara Y, Tsukahara S, Kitahata LM, Collins JG. The effects of an intrathecal NMDA antagonist (AP5) on the behavioral changes induced by colorectal inflammation with turpentine in rats. Life Sci 1997;60:1359-1363.
58. Kakizaki H, Yoshiyama M, De Groat WC, Role of NMDA and AMPA glutaminergic transmission in spinal c-fos expression after urinary tract irritation. Am J Physiol Reg Int Comp Physiol 1996;270: R990-R996,
59. Zhai QZ, Traub RJ. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain 1999;83:321-329.
60. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002;42:553-583.
61. Minami T, Okuda-Ashitaka E, Hori Y, Sakuma S, Sugimoto T, Sakimura K, Mishina M, Ito S. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur J Neurosci 1999;11:1849-1856.
62. Nishiyama T. Interaction among NMDA receptor, NMDA glycine site and AMPA receptor antagonists in spinally mediated analgesia. Can J Anaesth 2000;47:693-698.
63. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001;64:327-363.
64. Sorkin L. IT ketorolac blocks NMDA-evoked spinal release of prostaglandin-E2 (PGE2) and thromboxane-B2 (TXB2) (abstr). Anesthesiology 1993;79:A908.
65. Minami T, Sugatani J, Sakimura K, Abe M, Mishina M, Ito S. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice. Br J Pharmacol 1997;120:1522-1526.
66. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998;88:82-88.
67. Magerl W, Fuchs PN, Meyer RA, Treede RD. Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain 2001;124:1754-1764.
68. Sengupta JN, Saha JK, Goyal RK. Stimulus-response function studies of esophageal mechanosensitive nociceptors in sympathetic afferents of opossum. J Neurophysiol 1990;64:796-812.
69. Fryscak T, Zenker W, Kantner D. Afferent and efferent innervation of the rat esophagus. A tracing study with horseradish peroxidase and nuclear yellow. Anat Embryol (Berl) 1984;170:63-70.
70. Hobson AR, Khan RW, Sarkar S, Furlong PL, Aziz Q. Development of esophageal hypersensitivity following experimental duodenal acidification. Am J Gastro (In Press).
71. Garrison DW, Chandler MJ, Foreman RD. Viscerosomatic convergence onto feline spinal neurons from esophagus, heart and stomach fields: effects of inflammation. Pain 1992;49:373-382.
72. Quartaroli M, Carignani C, DalForno G, Mugnaini M, Ugolini A, Arban R, Bettelini L, Maraia G, Belardetti F, Regiani A, Trist DG, Ratti E, DiFabio R, Corsi M. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. J Pharmacol Exp Ther 1999;290:158-169.